Complement activation by RPE cells preexposed to TNFα and IFNγ

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Complement activation by RPE cells preexposed to TNFα and IFNγ. / Udsen, Maja; Tagmose, Christian; Garred, Peter; Nissen, Mogens Holst; Faber, Carsten.

In: Experimental Eye Research, Vol. 218, 108982, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Udsen, M, Tagmose, C, Garred, P, Nissen, MH & Faber, C 2022, 'Complement activation by RPE cells preexposed to TNFα and IFNγ', Experimental Eye Research, vol. 218, 108982. https://doi.org/10.1016/j.exer.2022.108982

APA

Udsen, M., Tagmose, C., Garred, P., Nissen, M. H., & Faber, C. (2022). Complement activation by RPE cells preexposed to TNFα and IFNγ. Experimental Eye Research, 218, [108982]. https://doi.org/10.1016/j.exer.2022.108982

Vancouver

Udsen M, Tagmose C, Garred P, Nissen MH, Faber C. Complement activation by RPE cells preexposed to TNFα and IFNγ. Experimental Eye Research. 2022;218. 108982. https://doi.org/10.1016/j.exer.2022.108982

Author

Udsen, Maja ; Tagmose, Christian ; Garred, Peter ; Nissen, Mogens Holst ; Faber, Carsten. / Complement activation by RPE cells preexposed to TNFα and IFNγ. In: Experimental Eye Research. 2022 ; Vol. 218.

Bibtex

@article{7d3401bb113942b8ac9a601331b5a1e3,
title = "Complement activation by RPE cells preexposed to TNFα and IFNγ",
abstract = "Age-related macular degeneration (AMD) has been associated with both complement activation and increased levels of circulating cytokines. Here, we sougth to investigate if cytokine-preexposure of retinal pigment epithelial (RPE) leads to increased complement activation and deposition of membrane attack complex (MAC). Primary human RPE and the ARPE19 cell line cultured in serum-free conditions were preexposed to 100 ng/ml interferon-gamma (IFNγ) and 20 ng/ml tumor necrosis factor-alpha (TNFα) for 48 h followed by exposure to diluted serum from healthy donors or complement factor B deficient (CFBd) serum for 70 min. Deposition of membrane attack complexes (MAC) was examined by use of a MAC-ELISA kit and by immunofluorescence. Eculizumab (anti-C5) was examined for its ability to prevent deposition of MAC on RPE cells exposed to serum. Lactatdehydrogenase (LDH) and thiazolyl blue tetrazolium bromide (MTT) assays were used to assess cellular metabolism and survival. MAC was deposited only on RPE preexposed to both IFNγ and TNFα. Lack of complement factor B or inhibition of C5 abrogated the MAC-deposition on RPE cells, while reconstitution of CFBd serum with CFB resulted in MAC-deposition. MAC-deposition resulted in RPE-release of LDH, but unaltered mitochondrial activity estimated by MTT. We conclude that preexposure of primary RPE and ARPE19 with inflammatory cytokines promoted alternative pathway activation of complement and deposition of MAC. This implies that circulating inflammatory mediators may increase susceptibility to local complement activation and MAC-deposition, which may represent an early event in the pathogenesis leading to AMD development.",
keywords = "Complement, Interferons, Membrane attack complex, Retinal pigment epithelium, Tumor necrosis factor",
author = "Maja Udsen and Christian Tagmose and Peter Garred and Nissen, {Mogens Holst} and Carsten Faber",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
doi = "10.1016/j.exer.2022.108982",
language = "English",
volume = "218",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press",

}

RIS

TY - JOUR

T1 - Complement activation by RPE cells preexposed to TNFα and IFNγ

AU - Udsen, Maja

AU - Tagmose, Christian

AU - Garred, Peter

AU - Nissen, Mogens Holst

AU - Faber, Carsten

N1 - Publisher Copyright: © 2022 The Authors

PY - 2022

Y1 - 2022

N2 - Age-related macular degeneration (AMD) has been associated with both complement activation and increased levels of circulating cytokines. Here, we sougth to investigate if cytokine-preexposure of retinal pigment epithelial (RPE) leads to increased complement activation and deposition of membrane attack complex (MAC). Primary human RPE and the ARPE19 cell line cultured in serum-free conditions were preexposed to 100 ng/ml interferon-gamma (IFNγ) and 20 ng/ml tumor necrosis factor-alpha (TNFα) for 48 h followed by exposure to diluted serum from healthy donors or complement factor B deficient (CFBd) serum for 70 min. Deposition of membrane attack complexes (MAC) was examined by use of a MAC-ELISA kit and by immunofluorescence. Eculizumab (anti-C5) was examined for its ability to prevent deposition of MAC on RPE cells exposed to serum. Lactatdehydrogenase (LDH) and thiazolyl blue tetrazolium bromide (MTT) assays were used to assess cellular metabolism and survival. MAC was deposited only on RPE preexposed to both IFNγ and TNFα. Lack of complement factor B or inhibition of C5 abrogated the MAC-deposition on RPE cells, while reconstitution of CFBd serum with CFB resulted in MAC-deposition. MAC-deposition resulted in RPE-release of LDH, but unaltered mitochondrial activity estimated by MTT. We conclude that preexposure of primary RPE and ARPE19 with inflammatory cytokines promoted alternative pathway activation of complement and deposition of MAC. This implies that circulating inflammatory mediators may increase susceptibility to local complement activation and MAC-deposition, which may represent an early event in the pathogenesis leading to AMD development.

AB - Age-related macular degeneration (AMD) has been associated with both complement activation and increased levels of circulating cytokines. Here, we sougth to investigate if cytokine-preexposure of retinal pigment epithelial (RPE) leads to increased complement activation and deposition of membrane attack complex (MAC). Primary human RPE and the ARPE19 cell line cultured in serum-free conditions were preexposed to 100 ng/ml interferon-gamma (IFNγ) and 20 ng/ml tumor necrosis factor-alpha (TNFα) for 48 h followed by exposure to diluted serum from healthy donors or complement factor B deficient (CFBd) serum for 70 min. Deposition of membrane attack complexes (MAC) was examined by use of a MAC-ELISA kit and by immunofluorescence. Eculizumab (anti-C5) was examined for its ability to prevent deposition of MAC on RPE cells exposed to serum. Lactatdehydrogenase (LDH) and thiazolyl blue tetrazolium bromide (MTT) assays were used to assess cellular metabolism and survival. MAC was deposited only on RPE preexposed to both IFNγ and TNFα. Lack of complement factor B or inhibition of C5 abrogated the MAC-deposition on RPE cells, while reconstitution of CFBd serum with CFB resulted in MAC-deposition. MAC-deposition resulted in RPE-release of LDH, but unaltered mitochondrial activity estimated by MTT. We conclude that preexposure of primary RPE and ARPE19 with inflammatory cytokines promoted alternative pathway activation of complement and deposition of MAC. This implies that circulating inflammatory mediators may increase susceptibility to local complement activation and MAC-deposition, which may represent an early event in the pathogenesis leading to AMD development.

KW - Complement

KW - Interferons

KW - Membrane attack complex

KW - Retinal pigment epithelium

KW - Tumor necrosis factor

U2 - 10.1016/j.exer.2022.108982

DO - 10.1016/j.exer.2022.108982

M3 - Journal article

C2 - 35183540

AN - SCOPUS:85125468217

VL - 218

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

M1 - 108982

ER -

ID: 300287056